This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia & Upjohn Company. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: The Innovations of Mats Kihlén
Introduction
Mats Kihlén is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of biotechnology, particularly in the area of matrix metalloproteinases. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Mats Kihlén holds a patent related to matrix metalloproteinases. The present invention provides genes encoding novel matrix metalloproteinases termed MMP. It includes constructs and recombinant host cells incorporating the genes, the MMP polypeptides encoded by the genes, antibodies to the MMP polypeptides, and methods of making and using all of the foregoing. This patent highlights his expertise and commitment to advancing scientific knowledge.
Career Highlights
Kihlén has worked with Pharmacia & Upjohn Company, where he has been able to apply his innovative ideas in a practical setting. His role in the company has allowed him to contribute to significant advancements in biotechnology and pharmaceuticals.
Collaborations
Mats Kihlén has collaborated with notable colleagues such as Timothy Wood and Jonas Ekblom. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and innovation.
Conclusion
Mats Kihlén's contributions to the field of biotechnology through his patent on matrix metalloproteinases exemplify the impact of innovation in medicine. His work continues to inspire future advancements in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile